Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

284 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
G1 phase progression: cycling on cue.
Sherr CJ. Sherr CJ. Cell. 1994 Nov 18;79(4):551-5. doi: 10.1016/0092-8674(94)90540-1. Cell. 1994. PMID: 7954821 Review. No abstract available.
Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.
Vo BT, Li C, Morgan MA, Theurillat I, Finkelstein D, Wright S, Hyle J, Smith SMC, Fan Y, Wang YD, Wu G, Orr BA, Northcott PA, Shilatifard A, Sherr CJ, Roussel MF. Vo BT, et al. Among authors: sherr cj. Cell Rep. 2017 Mar 21;18(12):2907-2917. doi: 10.1016/j.celrep.2017.02.073. Cell Rep. 2017. PMID: 28329683 Free PMC article.
Hzf, a p53-responsive gene, regulates maintenance of the G2 phase checkpoint induced by DNA damage.
Sugimoto M, Gromley A, Sherr CJ. Sugimoto M, et al. Among authors: sherr cj. Mol Cell Biol. 2006 Jan;26(2):502-12. doi: 10.1128/MCB.26.2.502-512.2006. Mol Cell Biol. 2006. PMID: 16382142 Free PMC article.
N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and p27Kip1 coordinately regulate cerebellar development.
Zindy F, Knoepfler PS, Xie S, Sherr CJ, Eisenman RN, Roussel MF. Zindy F, et al. Among authors: sherr cj. Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11579-83. doi: 10.1073/pnas.0604727103. Epub 2006 Jul 24. Proc Natl Acad Sci U S A. 2006. PMID: 16864777 Free PMC article.
A New Cell-Cycle Target in Cancer - Inhibiting Cyclin D-Dependent Kinases 4 and 6.
Sherr CJ. Sherr CJ. N Engl J Med. 2016 Nov 17;375(20):1920-1923. doi: 10.1056/NEJMp1612343. N Engl J Med. 2016. PMID: 27959598 No abstract available.
Differential post-transcriptional regulation of two Ink4 proteins, p18 Ink4c and p19 Ink4d.
Forget A, Ayrault O, den Besten W, Kuo ML, Sherr CJ, Roussel MF. Forget A, et al. Among authors: sherr cj. Cell Cycle. 2008 Dec;7(23):3737-46. doi: 10.4161/cc.7.23.7187. Epub 2008 Dec 13. Cell Cycle. 2008. PMID: 19029828 Free PMC article.
Oncogenic potential of the c-FMS proto-oncogene (CSF-1 receptor).
Roussel MF, Sherr CJ. Roussel MF, et al. Among authors: sherr cj. Cell Cycle. 2003 Jan-Feb;2(1):5-6. doi: 10.4161/cc.2.1.295. Cell Cycle. 2003. PMID: 12695672 Review. No abstract available.
Expression arrays illuminate a way forward for mantle cell lymphoma.
Evans WE, Cheok M, Yang W, Sherr CJ. Evans WE, et al. Among authors: sherr cj. Cancer Cell. 2003 Feb;3(2):100-2. doi: 10.1016/s1535-6108(03)00023-0. Cancer Cell. 2003. PMID: 12620403 No abstract available.
An Arf(GFP/GFP) reporter mouse reveals that the Arf tumor suppressor monitors latent oncogenic signals in vivo.
Sherr CJ. Sherr CJ. Cell Cycle. 2004 Mar;3(3):239-40. doi: 10.4161/cc.3.3.674. Epub 2004 Mar 1. Cell Cycle. 2004. PMID: 14726696
Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3.
Kuo ML, den Besten W, Thomas MC, Sherr CJ. Kuo ML, et al. Among authors: sherr cj. Cell Cycle. 2008 Nov 1;7(21):3378-87. doi: 10.4161/cc.7.21.6930. Epub 2008 Nov 4. Cell Cycle. 2008. PMID: 18948745
284 results
Jump to page
Feedback